Nutrient pattern analysis in critically ill patients using Omics technology (NAChO) - Study protocol for a prospective observational study.


Journal

Medicine
ISSN: 1536-5964
Titre abrégé: Medicine (Baltimore)
Pays: United States
ID NLM: 2985248R

Informations de publication

Date de publication:
Jan 2019
Historique:
entrez: 5 1 2019
pubmed: 5 1 2019
medline: 17 1 2019
Statut: ppublish

Résumé

Intensive care unit-acquired weakness (ICU-AW) is often observed in critically ill patients with prolonged intensive care unit (ICU) stay. We hypothesized that evolving metabolic abnormalities during prolonged ICU stay are reflected by changing nutrient patterns in blood, urine and skeletal muscle, and that these patterns differ in patients with/without ICU-AW and between patients with/without sepsis. In a prospective single-center observational trial, we aim to recruit 100 critically ill patients (ICU length of stay ≥ 5 days) with severe sepsis/septic shock ("sepsis group", n = 50) or severe head trauma/intracerebral hemorrhage ("CNS group", n = 50). Patients will be sub-grouped for presence or absence of ICU-AW as determined by the Medical Research Council sum score. Blood and urine samples will be collected and subjected to comprehensive nutrient analysis at different time points by targeted quantitative mass spectrometric methods. In addition, changes in muscular tissue (biopsy, when available), muscular architecture (ultrasound), electrophysiology, body composition analyses (bioimpedance, cerebral magnetic resonance imaging), along with clinical status will be assessed. Patients will be followed-up for 180 and 360 days including assessment of quality of life. Key objective of this trial is to assess changes in nutrient pattern in blood and urine over time in critically ill patients with/without ICU-AW by using quantitative nutrient analysis techniques. Peer-reviewed published NAChO data will allow for a better understanding of metabolic changes in critically ill patients on standard liquid enteral nutrition and will likely open up new avenues for future therapeutic and nutritional interventions.

Identifiants

pubmed: 30608424
doi: 10.1097/MD.0000000000013937
pii: 00005792-201901040-00044
pmc: PMC6344160
doi:

Substances chimiques

Nutrients 0

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

e13937

Références

Chest. 2016 Nov;150(5):1129-1140
pubmed: 27063347
Acta Neurol Scand. 2018 Aug;138(2):104-114
pubmed: 29845614
JAMA. 2001 Dec 5;286(21):2703-10
pubmed: 11730446
Intensive Care Med. 2011 Dec;37(12):1951-61
pubmed: 22048718
Bioinformatics. 2009 Apr 1;25(7):890-6
pubmed: 19244389
Intensive Care Med. 2010 Jan;36(1):66-74
pubmed: 19760204
Curr Opin Clin Nutr Metab Care. 2018 Mar;21(2):121-125
pubmed: 29251691
J Crit Care. 2015 Oct;30(5):1151.e9-14
pubmed: 26211979
Lancet Neurol. 2011 Oct;10(10):931-41
pubmed: 21939902
J Cell Biochem. 2013 Jun;114(6):1294-305
pubmed: 23238742
Am J Respir Crit Care Med. 2017 Dec 1;196(11):1422-1433
pubmed: 28809518
Chest. 2018 Dec;154(6):1395-1403
pubmed: 30144420
Physiol Rev. 2015 Jul;95(3):1025-109
pubmed: 26133937
Am J Respir Crit Care Med. 2010 Aug 15;182(4):446-54
pubmed: 20448093
Anaesth Intensive Care. 2010 Mar;38(2):307-16
pubmed: 20369765
J Proteome Res. 2017 May 5;16(5):2080-2090
pubmed: 28383921
Ann Transl Med. 2018 Jan;6(2):29
pubmed: 29430446
J Appl Physiol (1985). 2000 Jul;89(1):81-8
pubmed: 10904038
Neurohospitalist. 2017 Jan;7(1):41-48
pubmed: 28042370
J Cachexia Sarcopenia Muscle. 2010 Dec;1(2):147-157
pubmed: 21475702
Chest. 2016 Oct;150(4):966-971
pubmed: 27312737
Crit Care. 2017 Jul 28;21(1):193
pubmed: 28750641
Int J Biochem Cell Biol. 2013 Oct;45(10):2147-57
pubmed: 23769967
Crit Care. 2015 Aug 05;19:274
pubmed: 26242743
Scand J Infect Dis. 2010 Mar;42(3):164-71
pubmed: 19958238
Handb Clin Neurol. 2017;141:531-543
pubmed: 28190434
Intensive Care Med. 2006 Feb;32(2):251-259
pubmed: 16468072
Reprod Fertil Dev. 2011;23(5):619-32
pubmed: 21635810
Anal Chem. 2017 Jul 18;89(14):7615-7622
pubmed: 28578567
J Cachexia Sarcopenia Muscle. 2016 Sep;7(4):403-12
pubmed: 27030815

Auteurs

Joerg C Schefold (JC)

Department of Intensive Care Medicine, Inselspital, Bern University Hospital, University of Bern, Switzerland.

Anna S Messmer (AS)

Department of Intensive Care Medicine, Inselspital, Bern University Hospital, University of Bern, Switzerland.

Stefanie Wenger (S)

Department of Intensive Care Medicine, Inselspital, Bern University Hospital, University of Bern, Switzerland.

Lionel Müller (L)

Department of Intensive Care Medicine, Inselspital, Bern University Hospital, University of Bern, Switzerland.

Stephan von Haehling (S)

Metabolic Research Unit, Department Cardiology and Pneumology, University of Göttingen, Göttingen, Germany.

Wolfram Doehner (W)

Neuro Research Center, Charite University Medicine Berlin, Berlin, Germany.

Jamie S McPhee (JS)

Musculoskeletal Science and Sports Medicine Research Centre, Manchester Metropolitan University, Manchester, United Kingdom.

Michaela Fux (M)

Clinical Cytomics Facility, University Institute of Clinical Chemistry and Centre of Laboratory Medicine.

Kai M Rösler (KM)

Department of Neurology.

Olivier Scheidegger (O)

Department of Neurology.

Radu Olariu (R)

Department of Plastic Surgery.

Werner Z'Graggen (W)

Depts. of Neurosurgery and Neurology, Inselspital, Bern University Hospital, University of Bern.

Serge Rezzi (S)

Nestlé Research, vers-chez-les-Blanc, Lausanne.
Swiss Vitamin Institute, Epalinges, Switzerland.

Dominik Grathwohl (D)

Nestlé Research, vers-chez-les-Blanc, Lausanne.

Tobias Konz (T)

Nestlé Research, vers-chez-les-Blanc, Lausanne.

Jukka Takala (J)

Department of Intensive Care Medicine, Inselspital, Bern University Hospital, University of Bern, Switzerland.

Bernard Cuenoud (B)

Nestlé Health Science.

Stephan M Jakob (SM)

Department of Intensive Care Medicine, Inselspital, Bern University Hospital, University of Bern, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH